Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ontaneda

Showing results (151-160 of 193) with videos related to

Pageof 20
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2022
Decentralised clinical trials in multiple sclerosis researchAfagh Garjani, Brandon Jun-Yu Liu, Christopher Martin Allen, et al.
Multiple Sclerosis and Related Disorders|October 26, 2022
Benefits of early treatment with natalizumab: a real-world studyDaniel Ontaneda, Ellen M Mowry, Scott D Newsome, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 22, 2021
Juxtacortical susceptibility changes in progressive multifocal leukoencephalopathy at the gray-white matter junction correlates with iron-enriched macrophagesKedar R Mahajan, Moein Amin, Matthew Poturalski, et al.
Neurology. Clinical Practice|August 25, 2018
Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centersBrandi Vollmer, Daniel Ontaneda, Anasua Bandyopadhyay, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 27, 2025
Longitudinal modeling of upper extremity function in multiple sclerosis: Associations for clinical and sociodemographic factorsFarren Bs Briggs, Jiayue Yang, Karlo Toljan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 9, 2025
Forever youngJaume Sastre-Garriga, Jennifer Graves, Daniel Ontaneda, et al.
The Lancet. Neurology|August 26, 2018
Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective studyBruce D Trapp, Megan Vignos, Jessica Dudman, et al.
Multiple Sclerosis and Related Disorders|November 24, 2019
Technology-enabled comprehensive characterization of multiple sclerosis in clinical practiceLaura E Baldassari, Kunio Nakamura, Brandon P Moss, et al.
Acta Neuropathologica Communications|June 15, 2022
Visual imaging as a predictor of neurodegeneration in experimental autoimmune demyelination and multiple sclerosisGabrielle M Mey, Kirsten S Evonuk, McKenzie K Chappell, et al.
Multiple Sclerosis and Related Disorders|October 2, 2023
Magnetic resonance fingerprinting in multiple sclerosisDaniel Ontaneda, Vikas Gulani, Anagha Deshmane, et al.
Pageof 20

Showing results (151-160 of 193) with videos related to

Sort By:
Pageof 20
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2022
Decentralised clinical trials in multiple sclerosis researchAfagh Garjani, Brandon Jun-Yu Liu, Christopher Martin Allen, et al.
Multiple Sclerosis and Related Disorders|October 26, 2022
Benefits of early treatment with natalizumab: a real-world studyDaniel Ontaneda, Ellen M Mowry, Scott D Newsome, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 22, 2021
Juxtacortical susceptibility changes in progressive multifocal leukoencephalopathy at the gray-white matter junction correlates with iron-enriched macrophagesKedar R Mahajan, Moein Amin, Matthew Poturalski, et al.
Neurology. Clinical Practice|August 25, 2018
Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centersBrandi Vollmer, Daniel Ontaneda, Anasua Bandyopadhyay, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 27, 2025
Longitudinal modeling of upper extremity function in multiple sclerosis: Associations for clinical and sociodemographic factorsFarren Bs Briggs, Jiayue Yang, Karlo Toljan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 9, 2025
Forever youngJaume Sastre-Garriga, Jennifer Graves, Daniel Ontaneda, et al.
The Lancet. Neurology|August 26, 2018
Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective studyBruce D Trapp, Megan Vignos, Jessica Dudman, et al.
Multiple Sclerosis and Related Disorders|November 24, 2019
Technology-enabled comprehensive characterization of multiple sclerosis in clinical practiceLaura E Baldassari, Kunio Nakamura, Brandon P Moss, et al.
Acta Neuropathologica Communications|June 15, 2022
Visual imaging as a predictor of neurodegeneration in experimental autoimmune demyelination and multiple sclerosisGabrielle M Mey, Kirsten S Evonuk, McKenzie K Chappell, et al.
Multiple Sclerosis and Related Disorders|October 2, 2023
Magnetic resonance fingerprinting in multiple sclerosisDaniel Ontaneda, Vikas Gulani, Anagha Deshmane, et al.
Pageof 20